Continuing Risk of Ipsilateral Breast Relapse After Breast-Conserving Therapy at Long-Term Follow-up

International Journal of Radiation Oncology Biology Physics

Volumn 71, Issue 4, 2008, Pages 1014-1021

  Kreike, Bas ^a   Hart, Augustinus A M ^a   van de Velde, Tony ^a   Borger, Jacques ^b   Peterse, Hans ^a   Rutgers, Emiel ^a   Bartelink, Harry ^a   van de Vijver, Marc J ^a  

^a NETHERLANDS CANCER INSTITUTE   (Netherlands)

^b MAASTRO CLINIC   (Netherlands)

Author keywords

Breast neoplasm; Breast conserving therapy; Local neoplasm recurrence; Radiotherapy; Risk factors

Indexed keywords

ADMINISTRATIVE DATA PROCESSING; DECISION MAKING; FINANCIAL DATA PROCESSING; FOOD PROCESSING; MULTIVARIANT ANALYSIS; PATIENT MONITORING; PESTICIDE EFFECTS; PIGMENTS; RANDOM VARIABLES; REGRESSION ANALYSIS; RISK ANALYSIS; RISK ASSESSMENT; RISKS; STATISTICS;

BREAST CANCERS; BREAST CONSERVING THERAPY (BCT); CLINICAL INFORMATION; CONFIDENCE INTERVAL (CI); COX REGRESSION ANALYSIS; ELSEVIER (CO); HAZARD RATIO (HR); IN-SITU; MULTIVARIATE ANALYSIS (MVA); NETHERLANDS; RISK FACTORS; SURGICAL RESECTION; UNIVARIATE ANALYSIS; VASCULAR INVASION;

VIDEO AMPLIFIERS;

ADULT; ARTICLE; BREAST CANCER; CANCER INVASION; CANCER RELAPSE; CANCER RISK; CONSERVATIVE TREATMENT; FOLLOW UP; HUMAN; INCIDENCE; LONG TERM CARE; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; RISK FACTOR; TREATMENT OUTCOME;

ADULT; AGED; BREAST NEOPLASMS; COHORT STUDIES; FEMALE; FOLLOW-UP STUDIES; HUMANS; MASTECTOMY, SEGMENTAL; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NETHERLANDS; PREVALENCE; PROGNOSIS; RADIOTHERAPY; RISK ASSESSMENT; RISK FACTORS; TREATMENT OUTCOME;

EID: 45949083889     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2007.11.029     Document Type: Article

References (34)

1. Blichert-Toft M., Rose C., Andersen J.A., et al., Danish Breast Cancer Cooperative Group. Danish randomized trial comparing breast conservation therapy with mastectomy: Six years of life-table analysis. J Natl Cancer Inst Monogr 11 (1992) 19-25
2. Fisher B., Anderson S., Bryant J., et al. Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer. N Engl J Med 347 (2002) 1233-1241
3. Sarrazin D., Le M.G., Arriagada R., et al. Ten-year results of a randomized trial comparing a conservative treatment to mastectomy in early breast cancer. Radiother Oncol 14 (1989) 177-184
4. van Dongen J.A., Voogd A.C., Fentiman I.S., et al. Long-term results of a randomized trial comparing breast-conserving therapy with mastectomy: European Organization for Research and Treatment of Cancer 10801 trial. J Natl Cancer Inst 92 (2000) 1143-1150
5. Veronesi U., Cascinelli N., Mariani L., et al. Twenty-year follow-up of a randomized study comparing breast-conserving surgery with radical mastectomy for early breast cancer. N Engl J Med 347 (2002) 1227-1232
6. Bartelink H., Horiot J.C., Poortmans P., et al. Recurrence rates after treatment of breast cancer with standard radiotherapy with or without additional radiation. N Engl J Med 345 (2001) 1378-1387
7. Borger J., Kemperman H., Hart A., et al. Risk factors in breast-conservation therapy. J Clin Oncol 12 (1994) 653-660
8. Elkhuizen P.H., van de Vijver M.J., Hermans J., et al. Local recurrence after breast-conserving therapy for invasive breast cancer: High incidence in young patients and association with poor survival. Int J Radiat Oncol Biol Phys 40 (1998) 859-867
9. Elkhuizen P.H., Voogd A.C., van den Broek L.C., et al. Risk factors for local recurrence after breast-conserving therapy for invasive carcinomas: A case-control study of histological factors and alterations in oncogene expression. Int J Radiat Oncol Biol Phys 45 (1999) 73-83
10. Elkhuizen P.H., van Slooten H.J., Clahsen P.C., et al. High local recurrence risk after breast-conserving therapy in node-negative premenopausal breast cancer patients is greatly reduced by one course of perioperative chemotherapy: A European Organization for Research and Treatment of Cancer Breast Cancer Cooperative Group study. J Clin Oncol 18 (2000) 1075-1083
11. Park C.C., Mitsumori M., Nixon A., et al. Outcome at 8 years after breast-conserving surgery and radiation therapy for invasive breast cancer: Influence of margin status and systemic therapy on local recurrence. J Clin Oncol 18 (2000) 1668-1675
12. Voogd A.C., Peterse J.L., Crommelin M.A., et al., Dutch Study Group on Local Recurrence after Breast Conservation (BORST). Histological determinants for different types of local recurrence after breast-conserving therapy of invasive breast cancer. Eur J Cancer 35 (1999) 1828-1837
13. Vrieling C., Collette L., Fourquet A., et al. Can patient-, treatment- and pathology-related characteristics explain the high local recurrence rate following breast-conserving therapy in young patients?. Eur J Cancer 39 (2003) 932-944
14. Fredriksson I., Liljegren G., Palm-Sjovall M., et al. Risk factors for local recurrence after breast-conserving surgery. Br J Surg 90 (2003) 1093-1102
15. Voogd A.C., Nielsen M., Peterse J.L., et al. Differences in risk factors for local and distant recurrence after breast-conserving therapy or mastectomy for stage I and II breast cancer: Pooled results of two large European randomized trials. J Clin Oncol 19 (2001) 1688-1697
16. Cowen D., Jacquemier J., Houvenaeghel G., et al. Local and distant recurrence after conservative management of "very low-risk" breast cancer are dependent events: A 10-year follow-up. Int J Radiat Oncol Biol Phys 41 (1998) 801-807
17. Cowen D., Houvenaeghel G., Bardou V., et al. Local and distant failures after limited surgery with positive margins and radiotherapy for node-negative breast cancer. Int J Radiat Oncol Biol Phys 47 (2000) 305-312
18. Magee B., Swindell R., Harris M., et al. Prognostic factors for breast recurrence after conservative breast surgery and radiotherapy: Results from a randomised trial. Radiother Oncol 39 (1996) 223-227
19. Nixon A.J., Schnitt S.J., Gelman R., et al. Relationship of tumor grade to other pathologic features and to treatment outcome of patients with early stage breast carcinoma treated with breast-conserving therapy. Cancer 78 (1996) 1426-1431
20. de Bock G.H., van der Hage J.A., Putter H., et al. Isolated loco-regional recurrence of breast cancer is more common in young patients and following breast conserving therapy: Long-term results of European Organisation for Research and Treatment of Cancer studies. Eur J Cancer 42 (2006) 351-356
21. Komoike Y., Akiyama F., Iino Y., et al. Ipsilateral breast tumor recurrence (IBTR) after breast-conserving treatment for early breast cancer: Risk factors and impact on distant metastases. Cancer 106 (2006) 35-41
22. Fourquet A., Campana F., Zafrani B., et al. Prognostic factors of breast recurrence in the conservative management of early breast cancer: A 25-year follow-up. Int J Radiat Oncol Biol Phys 17 (1989) 719-725
23. Clarke M., Collins R., Darby S., et al. Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: An overview of the randomised trials. Lancet 366 (2005) 2087-2106
24. Voogd A.C., van Oost F.J., Rutgers E.J., et al. Long-term prognosis of patients with local recurrence after conservative surgery and radiotherapy for early breast cancer. Eur J Cancer 41 (2005) 2637-2644
25. van Dongen J.A. Subclavicular biopsy as a guideline for the treatment of breast cancer. World J Surg 1 (1977) 306-308
26. van Tienhoven G., Borger J.H., Passchier D.H., et al. The prognostic significance of the axillary apex biopsy in clinically operable breast cancer. Eur J Cancer 31A (1995) 1965-1968
27. Touboul E., Buffat L., Belkacemi Y., et al. Local recurrences and distant metastases after breast-conserving surgery and radiation therapy for early breast cancer. Int J Radiat Oncol Biol Phys 43 (1999) 25-38
28. Steel G. Basic clinical radiobiology. 3rd ed. (2002), Arnold, London, United Kingdom
29. Huang J., Barbera L., Brouwers M., et al. Does delay in starting treatment affect the outcomes of radiotherapy? A systematic review. J Clin Oncol 21 (2003) 555-563
30. Poortmans P., Bartelink H., Horiot J.C., et al. The influence of the boost technique on local control in breast conserving treatment in the EORTC "boost versus no boost" randomised trial. Radiother Oncol 72 (2004) 25-33
31. Elkhuizen P.H., van Slooten H.J., Clahsen P.C., et al. High local recurrence risk after breast-conserving therapy in node-negative premenopausal breast cancer patients is greatly reduced by one course of perioperative chemotherapy: A European Organization for Research and Treatment of Cancer Breast Cancer Cooperative Group study. J Clin Oncol 18 (2000) 1075-1083
32. Fisher B., Dignam J., Mamounas E.P., et al. Sequential methotrexate and fluorouracil for the treatment of node-negative breast cancer patients with estrogen receptor-negative tumors: eight-year results from National Surgical Adjuvant Breast and Bowel Project (NSABP) B-13 and first report of findings from NSABP B-19 comparing methotrexate and fluorouracil with conventional cyclophosphamide, methotrexate, and fluorouracil. J Clin Oncol 14 (1996) 1982-1992
33. Haffty B.G., Wilmarth L., Wilson L., et al. Adjuvant systemic chemotherapy and hormonal therapy: Effect on local recurrence in the conservatively treated breast cancer patient. Cancer 73 (1994) 2543-2548
34. Rose M.A., Henderson I.C., Gelman R., et al. Premenopausal breast cancer patients treated with conservative surgery, radiotherapy and adjuvant chemotherapy have a low risk of local failure. Int J Radiat Oncol Biol Phys 17 (1989) 711-717